Related Experiment Video
Updated: Aug 5, 2026

13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Maximizing Cytologic Specimen Supernatants: a New Player in the Molecular Toolbox
Acta Cytologica
|August 3, 2026
Summary
Cytology specimen supernatants (CSS) offer a novel source for molecular testing (MT), potentially reducing specimen contamination and improving turnaround times. Further optimization is needed for widespread adoption in pathology.
Area of Science:
- Cytopathology
- Molecular Diagnostics
- Nucleic Acid Extraction
Background:
- Cytopathologists utilize various cytologic preparations for molecular testing (MT).
- Residual cytology specimens and cytology specimen supernatants (CSS) are emerging sources for nucleic acid extraction.
- CSS, typically discarded, can be repurposed for MT, preserving cellular material for other studies.
Purpose of the Study:
- To evaluate the utility of CSS for molecular testing.
- To understand the metrics for evaluating MT on CSS, including nucleic acid quantity, tumor percentage, and quality.
- To assess the impact of CSS on specimen contamination and turnaround time.
Main Methods:
- Review of studies evaluating analytic and clinical value of MT on CSS.
- Analysis of nucleic acid quantity (degradation value) and quality (sequencing-derived metrics, concordance).
- Assessment of specimen contamination and turnaround time in MT performed on CSS.
Main Results:
- CSS contains both cellular (genomic) and cell-free nucleic acid.
- MT on CSS demonstrates advantages in reduced specimen contamination and improved turnaround times.
- Variations in nucleic acid quantity and quality indicate a need for further specimen optimization.
Conclusions:
- CSS is a viable source for molecular testing, offering significant benefits.
- Understanding MT evaluation metrics is crucial for utilizing CSS effectively.
- Further optimization of CSS processing is recommended for broader clinical adoption.

